The Food & Drug Administration approved a multi-dose vial presentation of Audenz, a vaccine made by Summit-based Seqirus for individuals six months and older against bird flu, also known as influenza ...
The latest issue of The Joint Commission’s Ambulatory Advisor includes an article providing guidance for surgery centers to meet the requirements for the use of multi-dose vials. The Joint Commission ...
Credit: Getty Images. Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant. The Food and Drug Administration (FDA) has approved a multidose vial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results